MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3390/ph18111658

Медицинская библиотека · Pharmaceuticals (Basel, Switzerland) · 2025

Immunomodulatory Effects of Juzentaihoto on Fas-Mediated Apoptosis: Insights from Cancer Patients and In Vitro Models.

Ngo Quang Trung, Espinoza Jorge Luis, Li Hongyang, Inokuchi Masafumi, Nakanishi Yosuke, Morishita Eriko, Katagiri Takamasa, Kawahara Akihiro, Yoshizaki Tomokazu, Takami Akiyoshi, Ogawa-Ochiai Keiko

СтатьяПеревод в очереди

Аннотация

Background/

Objectives

Juzentaihoto (JTT), a traditional Kampo formula composed of ten medicinal herbs, is widely prescribed in Japan for immune enhancement and general health maintenance. This exploratory, open-label pilot study aimed to evaluate the feasibility and immunomodulatory effects of JTT in cancer patients and to explore its potential mechanisms of action.

Methods

Ten cancer patients received oral JTT (7.5 g/day) for 14 days, while healthy volunteers served as a reference group. Peripheral natural killer (NK) cell phenotypes and CD95 expression were analyzed by flow cytometry, and serum Fas ligand (FasL) concentrations were measured by ELISA. Complementary in vitro assays using PBS-extracted, autoclaved JTT were conducted to assess Fas/FasL-mediated apoptosis in Jurkat and primary T cells by flow cytometry and Western blotting for cleaved caspase-8 and -3. Additional experiments with staurosporine (intrinsic apoptosis) and TRAIL in OSC-19 carcinoma cells were performed to determine pathway specificity.

Results

In patients, most NK-cell markers showed no statistically significant within-subject changes, although a trend-level increase in NKp46 and a significant reduction in NK-cell CD95 expression (paired p = 0.014) were observed. Between-group differences primarily reflected baseline disparities between cancer patients and healthy controls. In vitro, JTT (50-100 µg/mL) partially attenuated FasL-induced apoptosis and reduced cleaved caspase-3 without affecting cleaved caspase-8, suggesting selective downstream modulation of the extrinsic pathway.

Conclusions

Within the limitations of a small, non-randomized cohort without placebo, these findings are hypothesis-generating and indicate that JTT selectively modulates Fas-mediated lymphocyte apoptosis without promoting tumor immune evasion. Further randomized trials and mechanistic studies incorporating co-culture or 3D tumor-immune models are warranted to confirm these observations and identify active constituents.

Для цитирования: Ngo Quang Trung, Espinoza Jorge Luis, Li Hongyang, Inokuchi Masafumi, Nakanishi Yosuke, Morishita Eriko, Katagiri Takamasa, Kawahara Akihiro, Yoshizaki Tomokazu, Takami Akiyoshi, Ogawa-Ochiai Keiko. Immunomodulatory Effects of Juzentaihoto on Fas-Mediated Apoptosis: Insights from Cancer Patients and In Vitro Models.. Pharmaceuticals (Basel, Switzerland). 2025. DOI: 10.3390/ph18111658.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.